Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...
Celiac disease management varies across the globe, with significant disparities in disease awareness and resources in high- and lower-income countries.